Latest Product Innovation News

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.

Acusensus Limited has successfully raised $30 million through a placement of 20 million shares at $1.50 each, supported by both existing and new investors. The capital injection aims to fuel business development, product innovation, and operational expansion.

Alexium International has acquired Microtek Laboratories’ microencapsulation and phase-change material business, backed by a $6.8 million entitlement offer to strengthen its manufacturing and innovation capabilities in the US.

Biome Australia has initiated its first human clinical trial for the proprietary probiotic strain Lactobacillus plantarum BMB18, aiming to validate its benefits for digestive and mood-related symptoms.

Myer Holdings Limited reported steady FY25 financial results with $4.076 billion in sales and outlined ambitious growth strategies at its Annual General Meeting, alongside key director re-elections and executive incentives.

Spenda Limited has successfully raised $1.4 million through a private placement, attracting both new and existing sophisticated investors to support its product development and working capital needs.

Wisr Limited has successfully closed its Share Purchase Plan, raising $1.22 million and reducing corporate debt by $7.5 million as part of a broader $10.6 million capital raise.

Premier Investments reported a robust FY25 with a 31% rise in net profit, driven by strong performances from Peter Alexander and Smiggle, alongside a strategic capital return plan including a $100 million share buyback.

Identitii Limited has announced a pro rata non-renounceable rights issue to raise approximately $2.88 million, partially underwritten by Beauvais Capital Pty Ltd. The funds will support the development and commercialisation of its BNDRY platform amid ongoing patent litigation risks.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

Collins Foods has reported record half-year results driven by strong revenue growth, margin expansion, and operational excellence across its Australian and European markets. The company also raised its profit guidance and declared a higher interim dividend.

Collins Foods Limited has reported record half-year revenues of $750.3 million, with underlying net profit after tax surging 29.5%. The company’s operational improvements and expansion in Europe underpin an upgraded FY26 outlook.